Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 study of propofol + alfentanil + lidocaine sedation mixture in adult cataract surgery
ChiCTR2100042644Phase 4Recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, alfentanil and lidocaine in cataract (5 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Modified Observer's Assessment of Alertness/Sedation score response. Started Feb 2021; status: recruiting.
02
Drugs
propofolalfentanillidocaine
03
Conditions
cataract
Beyond the preview
Go deeper on ChiCTR2100042644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042644.